Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Introduction For nearly a decade, dry powder within private equity companies worldwide has achieved record levels, climbing from $1.2 trillion in 2011 to $2.9 trillion in 2020. Competition for assets has been fierce, and that will likely continue. More investors are competing for a shorter supply of assets, and the management teams of potential targets are less willing or able to spend time and resources answering diligence requests.
It seems as if almost every other week a new healthcare megamerger is announced that is supposed to transform the industry. From Walmart-Humana to CVS-Aetna - to the recent announcement in the Dallas market around Baylor, Scott & White and Memorial Hermann - the continuous message is that disruption has arrived and the walls of traditional M&A are falling down. Last year, there were 579 deals for U.S. healthcare targets, the second highest total on record. Why is healthcare M&A so hot?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
